|
Dr. Robaugh joined Pyxant Labs Inc in August 2002 as Vice President. He has more than 17 years experience leading GLP studies, and more than 25 years experience in the development and application of state-of-the-art analytical techniques including LC/MS, MS-MS techniques, GC/MS, MALDI-TOF, and FAB. Moreover, Dr. Robaugh has extensive experience leading original research projects over a wide range of topics, including picogram-level bioanalytical method development, ADME, PK/PD, metabolism, toxicology bioanalytical support, and a wide range of sample preparation experience. His specialties include: pre-clinical drug development, HPLC/MS, MS-MS, trace-level bioassays, bioanalytical method development and validation (urine, plasma, serum, and various tissues), method troubleshooting, mass spectrometry, project management, experimental design, GLP, cGMP, and OECD regulated studies. Former positions included Midwest Research Institute, Kansas City. Dr. Robaugh’s education highlights are a B.S. in Chemistry, California State University of Pennsylvania and Ph.D., Physical Chemistry, West Virginia University. Dr. Robaugh’s professional affiliations include being a member of the American Chemical Society, the American Association of Pharmaceutical Scientists, and the Rocky Mountain Regional Chapter Society of Quality Assurance. | 